# Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

> **NCT06230055** · PHASE4 · RECRUITING · sponsor: **Fudan University** · enrollment: 37 (estimated)

## Conditions studied

- HER2-negative Breast Cancer
- Leptomeningeal Metastasis

## Interventions

- **DEVICE:** Ommaya reservoir
- **DRUG:** Systematic chemotherapy
- **DRUG:** Intrathecal chemotherapy

## Key facts

- **NCT ID:** NCT06230055
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-05
- **Primary completion:** 2026-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06230055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06230055, "Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06230055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*